Cargando…

Design, Synthesis, Activity and Docking Study of Sorafenib Analogs Bearing Sulfonylurea Unit

Two series of novel sorafenib analogs containing a sulfonylurea unit were synthesized and their chemical structures were confirmed by (1)H-NMR, (1)(3)C-NMR, MS spectrum and elemental analysis. The synthesized compounds were evaluated for the cytotoxicity against A549, Hela, MCF-7, and PC-3 cancer ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Chunjiang, Wang, Min, Tang, Qidong, Luo, Rong, Chen, Le, Zheng, Pengwu, Zhu, Wufu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6332012/ https://www.ncbi.nlm.nih.gov/pubmed/26512636 http://dx.doi.org/10.3390/molecules201019361

Ejemplares similares

Design, Synthesis and Biological Evaluation of 6,7-Disubstituted-4-phenoxyquinoline Derivatives Bearing Pyridazinone Moiety as c-Met Inhibitors
por: Liu, Xiaobo, et al.
Publicado: (2018)

Synthesis and Biological Evaluation of Novel 8-Morpholinoimidazo[1,2-a]pyrazine Derivatives Bearing Phenylpyridine/Phenylpyrimidine-Carboxamides
por: Xu, Shan, et al.
Publicado: (2017)

Design, Synthesis, and Antitumor Activity of Olmutinib Derivatives Containing Acrylamide Moiety
por: Hu, Xiaohan, et al.
Publicado: (2021)

Synthesis and Biological Evaluation of Novel 4-Morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine Derivatives Bearing Phenylpyridine/ Phenylpyrimidine-Carboxamides
por: Liu, Huimin, et al.
Publicado: (2016)

Synthesis and Structure–Activity Relationships of 4-Morpholino-7,8-Dihydro-5H-Thiopyrano[4,3-d]pyrimidine Derivatives Bearing Pyrazoline Scaffold
por: Wang, Qinqin, et al.
Publicado: (2017)

Discovery of novel quinazoline derivatives bearing semicarbazone moiety as potent EGFR kinase inhibitors
por: Tu, Yuanbiao, et al.
Publicado: (2018)

Design, Synthesis, and Biological Evaluation of Novel Thienopyrimidine Derivatives as PI3Kα Inhibitors
por: Yu, Lide, et al.
Publicado: (2019)

Research Progress of Small Molecule VEGFR/c-Met Inhibitors as Anticancer Agents (2016–Present)
por: Zhang, Qian, et al.
Publicado: (2020)

Discovery of Triazolo-pyridazine/-pyrimidine Derivatives Bearing Aromatic (Heterocycle)-Coupled Azole Units as Class II c-Met Inhibitors
por: Zhang, Qian, et al.
Publicado: (2020)

Indole bearing thiadiazole analogs: synthesis, β-glucuronidase inhibition and molecular docking study
por: Almandil, Noor Barak, et al.
Publicado: (2019)

Design, synthesis and biological evaluation of novel 4-anlinoquinazoline derivatives as EGFR inhibitors with the potential to inhibit the gefitinib-resistant nonsmall cell lung cancers
por: Wang, Caolin, et al.
Publicado: (2018)

Design, Synthesis, and Biological Evaluation of [1,2,4]triazolo[4,3-a] Pyrazine Derivatives as Novel Dual c-Met/VEGFR-2 Inhibitors
por: Liu, Xiaobo, et al.
Publicado: (2022)

Synthesis and Antitumor Activity of Triazole-Containing Sorafenib Analogs
por: Ye, Wenjing, et al.
Publicado: (2017)

Synthesis and bioevaluation of thienopyrimidines bearing a pyrazoline unit as selective PI3Kα inhibitors
por: Lai, Luogen, et al.
Publicado: (2019)

Design, Synthesis, and Biological Evaluation of Pyridineamide Derivatives Containing a 1,2,3-Triazole Fragment as Type II c-Met Inhibitors
por: Xiong, Hehua, et al.
Publicado: (2019)

Design, Synthesis and in Vivo Evaluation of Novel Glycosylated Sulfonylureas as Antihyperglycemic Agents
por: Suaifan, Ghadeer A. R. Y., et al.
Publicado: (2015)

Design, synthesis, and screening of sulfonylurea-derived NLRP3 inflammasome inhibitors
por: Kulkarni, Amol A., et al.
Publicado: (2019)

Design, synthesis, docking study and cytotoxic activity evaluation of some novel letrozole analogs
por: Vosooghi, Mohsen, et al.
Publicado: (2014)

Design, Synthesis, Antitumor Activity and Molecular Docking Study of Novel 5-Deazaalloxazine Analogs
por: Mahmoud, Sawsan, et al.
Publicado: (2020)

New Triazinoindole Bearing Benzimidazole/Benzoxazole Hybrids Analogs as Potent Inhibitors of Urease: Synthesis, In Vitro Analysis and Molecular Docking Studies
por: Mumtaz, Sundas, et al.
Publicado: (2022)

Design, synthesis, docking, and antidepressant activity evaluation of isatin derivatives bearing Schiff bases
por: Mesripour, Azadeh, et al.
Publicado: (2023)

Synthesis, characterization, and antiproliferative evaluation of novel sorafenib analogs for the treatment of hepatocellular carcinoma
por: Jihad, Marwan Imad, et al.
Publicado: (2023)

Customized synthesis of phosphoprotein bearing phosphoserine or its nonhydrolyzable analog
por: Liu, Dong, et al.
Publicado: (2022)

Solvent-Free Synthesis and Safener Activity of Sulfonylurea Benzothiazolines
por: Fu, Ying, et al.
Publicado: (2017)

Design, Synthesis, Molecular Modeling and Anti-Hyperglycemic Evaluation of Quinazoline-Sulfonylurea Hybrids as Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) and Sulfonylurea Receptor (SUR) Agonists
por: El-Zahabi, Mohamed Ayman, et al.
Publicado: (2022)

Synthesis, Molecular Docking and Biological Evaluation of Glycyrrhizin Analogs as Anticancer Agents Targeting EGFR
por: Yang, Yong-An, et al.
Publicado: (2014)

Design, Synthesis, and Docking Studies of New Torin2 Analogs as Potential ATR/mTOR Kinase Inhibitors †
por: Shaik, Althaf, et al.
Publicado: (2018)

Design, synthesis, and bioactivity evaluation of antitumor sorafenib analogues
por: Zhou, Shiyang, et al.
Publicado: (2018)

Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors
por: Sun, Shaofeng, et al.
Publicado: (2017)

Synthesis, antiplasmodial activity and in silico molecular docking study of pinocembrin and its analogs
por: Melaku, Yadessa, et al.
Publicado: (2022)

Molecular docking, synthesis, and antibacterial activity of the analogs of 1-allyl-3-benzoylthiourea
por: Shalas, Alvan F., et al.
Publicado: (2023)

Design, synthesis, and insecticidal activity of a novel series of flupyrimin analogs bearing 1-aryl-1H-pyrazol-4-yl subunits
por: Zhao, Fenghai, et al.
Publicado: (2022)

Design and Synthesis of Aminopyrimidinyl Pyrazole Analogs as PLK1 Inhibitors Using Hybrid 3D-QSAR and Molecular Docking
por: Bhujbal, Swapnil P., et al.
Publicado: (2022)

Sulfonylureas: Asset or liability?
por: Lakhani, Om J., et al.
Publicado: (2015)

Sulfonylureas at the Glomerular Battlefield
por: Kalra, Sanjay, et al.
Publicado: (2018)

Discovery of novel phthalimide analogs: Synthesis, antimicrobial and antitubercular screening with molecular docking studies
por: Rateb, Heba S., et al.
Publicado: (2016)

Synthesis of Benzimidazole–Based Analogs as Anti Alzheimer’s Disease Compounds and Their Molecular Docking Studies
por: Adalat, Bushra, et al.
Publicado: (2020)

Sulfonylurea action re‐revisited
por: Seino, Susumu, et al.
Publicado: (2010)

Sulfonylureas and their use in clinical practice
por: Sola, Daniele, et al.
Publicado: (2015)

Coumarin derivatives bearing benzoheterocycle moiety: synthesis, cholinesterase inhibitory, and docking simulation study
por: Hirbod, Kimia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uch2sffe1j162d1fva1frfolo3